Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Resectable Lung Non-Small Cell Carcinoma 1Psychological Well-Being 1Parasomnias 1Fatigue 1Depression 1Anxiety Disorders 1

Interventions

Fulvestrant 63Letrozole 53Paclitaxel 50Trastuzumab 42pembrolizumab 40ribociclib 38Specimen Handling 37palbociclib 36Capecitabine 35Carboplatin 33Anastrozole 33Tamoxifen 32exemestane 29pertuzumab 28abemaciclib 28Magnetic Resonance Spectroscopy 26Cyclophosphamide 26trastuzumab deruxtecan 25Surveys and Questionnaires 22Biopsy 19olaparib 18Standard of Care 18Radiotherapy 18Docetaxel 16Blood Specimen Collection 16elacestrant 14Taxes 14Mastectomy, Segmental 14eribulin 13Methods 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Neoplasms × Relaxation Therapy × 90 days × Clear all
NCT06924788 2026-05-28

VSMART

University of Alabama at Birmingham

Phase NA Enrolling by invitation
25 enrolled
Breast

Breast Neoplasms

NCT01202851 2026-05-05

Relaxation for Women With Breast Cancer Undergoing Radiotherapy

M.D. Anderson Cancer Center

Phase 3 Active not recruiting
681 enrolled
Breast

Psychological Well-Being, Breast Neoplasms, Fatigue, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡